DELIVERY ORDER
Active36C26026F0298
Department of Veterans Affairs › 260-NETWORK CONTRACT OFFICE 20 (36C260)
$469.1K
obligated · signed 4 months ago
PYLARIFY (PIFLUFOLASTAT F 18) INJECTIONS
Performance timeline
Start
Jul 1, 2026
End
Oct 31, 2026
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Oct 31, 2026
PROGENICS PHARMACEUTICALS INC
Contract 36C26026F0298
UEI
YLYKVRPCTCR3
Parent Company
LANTHEUS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$469,134
Base + Exercised Options
$469,134
Total Ceiling Value
$469,134
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
260-NETWORK CONTRACT OFFICE 20 (36C260)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
663-SEATTLE (00663)
Office
Contract Vehicle
36F79725D0093
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.